Winston-Salem, N.C. - Even before lesions begin to improve, patients with moderate to severe plaque psoriasis feel better a few weeks after starting efalizumab (Raptiva) therapy.
New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
Indoor Tanning and Melanoma
Skin Barrier 101: Keep Up with What Your Patients Are Reading